Résultat de recherche pour « follow up after root canal »

108 résultats pour « follow up after root canal »

ViiV Healthcare submits regulatory application to the European Medicines Agency for fostemsavir

London, 10 January 2020 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the submission of a marketing authorisation application (MAA) to the European Medicines Agency (EMA) seeking approval of fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV-1 infection.